Cura, Y.; Sánchez-MartÃn, A.; Márquez-Pete, N.; González-Flores, E.; MartÃnez-MartÃnez, F.; Pérez-RamÃrez, C.; Jiménez-Morales, A.
Association of Single-Nucleotide Polymorphisms in Capecitabine Bioactivation Pathway with Adjuvant Therapy Safety in Colorectal Cancer Patients. Pharmaceutics 2023, 15, 2548.
https://doi.org/10.3390/pharmaceutics15112548
AMA Style
Cura Y, Sánchez-MartÃn A, Márquez-Pete N, González-Flores E, MartÃnez-MartÃnez F, Pérez-RamÃrez C, Jiménez-Morales A.
Association of Single-Nucleotide Polymorphisms in Capecitabine Bioactivation Pathway with Adjuvant Therapy Safety in Colorectal Cancer Patients. Pharmaceutics. 2023; 15(11):2548.
https://doi.org/10.3390/pharmaceutics15112548
Chicago/Turabian Style
Cura, Yasmin, Almudena Sánchez-MartÃn, Noelia Márquez-Pete, Encarnación González-Flores, Fernando MartÃnez-MartÃnez, Cristina Pérez-RamÃrez, and Alberto Jiménez-Morales.
2023. "Association of Single-Nucleotide Polymorphisms in Capecitabine Bioactivation Pathway with Adjuvant Therapy Safety in Colorectal Cancer Patients" Pharmaceutics 15, no. 11: 2548.
https://doi.org/10.3390/pharmaceutics15112548
APA Style
Cura, Y., Sánchez-MartÃn, A., Márquez-Pete, N., González-Flores, E., MartÃnez-MartÃnez, F., Pérez-RamÃrez, C., & Jiménez-Morales, A.
(2023). Association of Single-Nucleotide Polymorphisms in Capecitabine Bioactivation Pathway with Adjuvant Therapy Safety in Colorectal Cancer Patients. Pharmaceutics, 15(11), 2548.
https://doi.org/10.3390/pharmaceutics15112548